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SUMMARY
Since 2004, efforts to improve poliovirus detection have significantly increased the volume of 
specimen testing from acute flaccid paralysis (AFP) patients in India. One option to decrease 
collection and testing burden would be collecting only a single stool specimen instead of two. We 
investigated stool specimen sensitivity for poliovirus detection in India to estimate the contribution 
of the second specimen. We reviewed poliovirus isolation data for 303984 children aged <15 years 
with AFP during 2000–2010. Using maximum-likelihood estimation, we determined specimen 
sensitivity of each stool specimen, combined sensitivity of both specimens, and sensitivity added 
by the second specimen. Of 5184 AFP patients with poliovirus isolates, 382 (7·4%) were identified 
only by the second specimen. Sensitivity was 91·4% for the first specimen and 84·5% for the 
second specimen; the second specimen added 7·3% sensitivity, giving a combined sensitivity of 
98·7%. Combined sensitivity declined, and added sensitivity increased, as the time from paralysis 
onset to stool collection increased (P = 0·032). The sensitivity added by the second specimen is 
important to detect the last chains of poliovirus transmission and to achieve certification of polio 
eradication. For sensitive surveillance, two stool specimens should continue to be collected from 
each AFP patient in India.
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INTRODUCTION
Acute flaccid paralysis (AFP) surveillance forms the basis for detection of poliovirus cases 
globally. In the Global Polio Eradication Initiative (GPEI), AFP is defined as rapid 
progression of weakness with loss of voluntary movement and loss of muscle tone in any 
part of the body in a patient aged <15 years; or paralysis in a person of any age in whom 
polio is suspected [1]. AFP surveillance was started in India in 1997, and includes case 
investigations of all persons with suspected AFP, with collection of two stool specimens for 
poliovirus isolation [2]. In 2004–2005, in an effort to increase the sensitivity of the AFP 
surveillance system, the AFP case definition was broadened to include transient weakness 
and facial paralysis. To further enhance sensitivity, the number of AFP case-reporting sites 
nationally increased from 21403 in 2004 to 36629 in 2012 in an effort to include health 
facilities serving migrant and high-risk populations [2]. As a likely consequence of changes 
to increase sensitivity, the non-polio AFP rate in India increased from 2·0 to 13·5 cases/
100000 population aged <15 years from 2000 to 2011, and is substantially higher than the 
World Health Organization (WHO) target rate of at least two non-polio AFP cases/100000 
population aged <15 years [2, 3]. However, increased reporting of AFP cases requires higher 
resources for both case investigations and laboratory testing [4, 5]. While AFP surveillance 
accounted for <10% of the overall cost of the polio eradication programme in India in 2011 
[6], AFP surveillance costs are not expected to decrease, even as India was removed from 
the WHO list of polio-endemic countries in January 2011, because of the need for a 
continued strong surveillance system [7].
Collection of two stool specimens is recommended by WHO because poliovirus is shed 
intermittently in stool, so testing only one sample could potentially miss an opportunity to 
detect the virus [8]. Nonetheless, collecting one stool specimen instead of two has been 
proposed as one way to reduce the case investigation and laboratory testing burden, and cost 
of the AFP surveillance system in India and other countries. In November 2010, the India 
Expert Advisory Group considered the role of the second stool sample for polio diagnosis in 
the context of the decline in reported polio cases from 266 in 2000 to 42 in 2010 [9]. Our 
study aimed to assess: (1) changes in stool collection and processing performance indicators, 
(2) the sensitivity of stool specimens in polio diagnosis, and (3) the number of polio cases 
identified only by the second specimen for AFP cases reported during 2000–2010. Using 
these results, we provide recommendations for maintaining high quality, sensitive AFP 
surveillance while taking into account limited programmatic resources.
METHODS
We restricted the analysis to AFP cases in children aged <15 years reported to the National 
Polio Surveillance Project – India from 2000 to 2010. Stool specimens were tested at one of 
eight national laboratories in the country using cell culture on two poliovirus-sensitive cell 
lines according to WHO standards, followed by antigenic and/or molecular characterization 
of isolates [10]. The first and second specimens from each individual were analysed by the 
same methodology. Stool collection and processing performance indicators were assessed 
using WHO criteria [1]. Two stool specimens should be collected from each AFP case-
patient within 14 days of paralysis onset and at least 24 h apart; each specimen must be of 
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adequate volume (8–10 g), and arrive at a WHO-accredited laboratory in good condition (i.e. 
no desiccation, no leakage, with adequate documentation and evidence that the cold chain 
was maintained) [1]. Polio cases were considered to be confirmed if wild poliovirus (WPV) 
type 1, WPV type 3, or vaccine-derived poliovirus (VDPV) was isolated in either stool 
specimen.
Polio cases with two stool results reported were further analysed to estimate single 
specimen, combined specimen, and added sensitivity. Methods for calculating the specimen 
sensitivity of each individual stool, the combined sensitivity of both first and second stool 
specimens (i.e. person sensitivity), and the added sensitivity of the second specimen have 
been described previously [11] (Fig. 1). In brief, this methodology derives maximum-
likelihood estimates for the specimen sensitivities for each stool, and the approximate 
variances of the estimators. Each stool sample was considered to be independent of the 
other; therefore, each stool sample serves as the gold standard estimate for the other 
specimen.
Sensitivity estimates for confirmed polio cases were calculated for the entire period during 
2000–2010 and by various factors, including stool adequacy, stool condition on arrival at the 
laboratory, and time interval of stool collection from onset of paralysis, patient age, and year. 
The Wald χ2 test was used to test for equality of mean specimen sensitivities across 
categories. Results were divided into three time categories: 2000–2004 (before the AFP case 
definition change), 2005–2009 (after the AFP case definition change), and 2010 (a year of 
particularly low reported polio cases). The number of polio cases identified only by the 
second stool specimen was determined for the overall period 2000–2010, and by the same 
factors as in the sensitivity analyses. The Cochran–Armitage trend test was used to test for 
trends in proportions across ordinal categories. Data were analysed in SAS v. 9.2 (SAS 
Institute Inc., USA) and R v. 2.12.1 (R Foundation, Austria).
RESULTS
AFP cases, laboratory samples processed and stool surveillance indicators
From 2000 to 2010, 303984 children aged <15 years with AFP were identified. Of these, 
290 763 (95·7%) had two stool samples with poliovirus isolation results reported, 2537 
(0·8%) were missing one poliovirus isolation result, and 10684 (3·5%) were missing both 
poliovirus isolation results. The median age of children with AFP was 37 months 
(interquartile range 22–71), 207 774 (68%) AFP cases were children aged <5 years, and 
108998 (41%) were females.
During 2000–2010, reported AFP cases increased from 8095 to 55616 and stool specimens 
processed by the laboratory increased from 15761 to 108 207 (Fig. 2). Confirmed polio 
cases fluctuated during 2000–2010, with peaks in 2002 (1603 cases), 2007 (877 cases), and 
2009 (763 cases), and troughs in 2005 (66 cases) and 2010 (47 cases) (Fig. 2).
Indicators of stool adequacy, timeliness of specimen collection, condition on arrival at the 
laboratory, and time interval from collection of first and second stool specimens were above 
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the WHO target level of 80% for the entire period of 2000–2010 (Table 1), with little 
fluctuation from year to year.
The mean interval from onset of paralysis to arrival of the second stool specimen at the 
laboratory was 14·7 days during 2000–2004, 13·0 days during 2005–2009, and 12·2 days 
during 2010 (Fig. 3). The mean time interval from onset of paralysis to collection of the first 
stool sample accounted for the largest percentage of the total time interval in all categories, 
and decreased by 14% from 9·2 days during 2000–2004 to 7·9 days during 2010. The mean 
time interval from collection of the second stool specimen to its being sent to the laboratory 
decreased by 72% from 3·2 days during 2000–2004 to 1·2 days during 2010.
Stool specimen sensitivity, combined sensitivity, and added sensitivity
Estimates of stool specimen sensitivity were calculated for the 5184 polio-confirmed cases 
with WPV type 1, WPV type 3, or VDPV isolated from at least one stool specimen (Table 
2).
During 2000–2010, the specimen sensitivity of the first stool (91·4%) was significantly 
higher than the specimen sensitivity of the second stool (84·5%) (P<0·0001), combined 
sensitivity was 98·7%, and the added sensitivity of the second stool specimen was 7·3% 
(Table 3). There were no differences in sensitivity estimates by time period category (P = 
0·960). Specimen sensitivity was significantly higher when both stool specimens were 
adequate than when either of the specimens were not adequate (P = 0·037). Of 350 
specimens where both specimens were not adequate, 316 (90·3%) were inadequate due to 
poor timeliness (both stools not collected within 14 days after the onset of paralysis) and 30 
(8·6%) were inadequate due to poor condition at the time of arrival at the laboratory.
Of the factors analysed affecting adequacy (stool condition, interval from onset of paralysis 
to collection of stool specimen 1, interval from collection of stool specimen 1 to collection 
of stool specimen 2), only interval from onset of paralysis to collection of stool specimen 1 
significantly affected sensitivity (P = 0·03) (Table 3). Specimens collected in the first week 
after the onset of paralysis had the highest specimen sensitivity (stool 1, 92·9%; stool 2, 
85·8%) and combined sensitivity (99·0%), and lowest added sensitivity (6·1%) compared to 
later weeks. When categorized by the WHO timeliness guideline, specimens collected ⩽14 
days after the onset of paralysis had significantly higher specimen sensitivity (stool 1, 
91·9%; stool 2, 85·4%) than specimens collected after the first 14 days (stool 1, 82·8%; stool 
2, 72·9%; P = 0·025). Specimens collected ⩽7 days after the onset of paralysis also had 
higher specimen and combined sensitivity, and lower added sensitivity, than those collected 
>7 days, although this difference was not statistically significant (P = 0·071).
Of children aged 60–180 months, specimen sensitivity was lower and added sensitivity was 
higher compared to specimen sensitivity and added sensitivity in children aged 0–59 
months; however, the difference in mean specimen sensitivity between age groups was not 
statistically significant (P = 0·069). A higher percentage of stools was collected after 14 days 
from children aged 60–180 months (21/160, 13%) than from children aged 0–59 months 
(298/5024, 6%).
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Cases identified by second stool specimen only
Of 5184 confirmed polio cases identified from 2000 to 2010, 382 (7·4%) were identified 
only by the second stool sample (Table 4). The percentage of cases identified only by the 
second stool sample was higher if both stools were inadequate (P=0·0001), as the stool 
collection interval increased (P<0·0001), and as patient age in months increased (P=0·0004). 
Of the 382 confirmed polio cases identified by the second stool specimen only, 38 (10%) 
were from 33 districts and nine states that had previously been polio-free for at least 6 
months (i.e. not geographically related to an ongoing outbreak).
DISCUSSION
The second stool specimen contributed an additional 7·3% sensitivity overall, resulting in a 
combined sensitivity of 98·7% for both specimens. Both the first and second specimens were 
most sensitive if collected in the first week after the onset of paralysis. The second specimen 
detected an additional 382 polio cases that would not otherwise have been identified, which 
represents 7·2% of all polio-confirmed cases reported during 2000–2010; 38 (10%) were not 
geographically related to an ongoing outbreak. These results highlight the substantial 
contribution of the second stool specimen in India in identifying polio cases.
The first stool specimen had higher specimen sensitivity (91·4%) than the second stool 
specimen (84·5%). Reasons for lower specimen sensitivity for the second specimen are 
unclear, but could be related to the later time of second stool collection after illness onset 
[11, 12], viral excretion patterns, or to factors related to second stool specimen collection. 
Nonetheless, the second specimen increased the sensitivity of detection of confirmed polio 
cases as indicated by added sensitivity and the absolute number of cases identified by the 
second specimen only.
The lower specimen sensitivities when specimens were inadequate and in older children are 
due in part to the later collection time for some of these samples. This has greater 
implications currently as polio is historically a disease of young childhood; now, however, 
cases are increasingly occurring in older children and even in adults [13, 14]. As a result, 
healthcare providers might not recognize polio as the cause of AFP in older age groups as 
quickly as they do in younger children, which could lead to delayed stool collection times. 
Alternatively, older children who have partial immunity might have transient, asymptomatic 
infection with intermittent viral shedding resulting in discordant stool sample results; these 
discordant results would in turn decrease sensitivity.
The percentage of cases identified only by the second sample (7·2%) is similar to findings of 
previous studies in Latin America (8%) [4] and from the USA (10%) [8] but is lower than 
estimates reported previously from India (21%) [15] and the Western Pacific region (31%) 
[16]. The lower estimate in our analysis compared to a previous analysis of India’s AFP 
surveillance system [15] could be due to improvements in the collection, storage and 
transport of specimens, as well as improved laboratory performance. Indeed, by 2000, both 
specimen sensitivity and the percentage of cases identified by the second stool sample (12%) 
approached comparable levels to the current analysis from 2000 to 2010. The fact that we 
did not find an increase in specimen sensitivity after 2000 suggests there may be a point at 
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which it is difficult to further increase specimen sensitivity despite improvements in field 
and laboratory performance.
The findings in this paper are subject to at least two limitations. First, the laboratories testing 
specimens changed during the analysis period and the prevalence of positive specimens 
going to specific laboratories also changed, making it difficult to assess laboratory-specific 
data over time. Second, for this analysis we must assume that isolation of poliovirus from 
one stool specimen is independent of the other. However, both samples are collected from 
the same AFP case-patient, often by the same health worker, and are usually transported 
together to the laboratory. Factors affecting specimen quality, including handling, packaging, 
and temperature, will affect both specimens equally, and may increase or decrease the 
laboratory’s ability to isolate poliovirus. This lack of complete independence could result in 
overestimating or underestimating sensitivity. Nonetheless, the contribution of the second 
specimen is still marked, as this limitation does not affect the number of cases that would 
not have been detected without the second specimen.
India’s AFP surveillance system is a ‘best-case’ scenario compared to other systems 
globally and caution should be exercised when generalizing the results to other areas with 
less highly functioning surveillance systems. On the other hand, some results from this study 
have important implications for other settings. It is a struggle to collect one stool specimen 
in some countries, and many specimens reach the laboratory in inadequate condition, or are 
collected too late after the onset of paralysis [17]. In these settings, specimen and combined 
sensitivity are likely to be lower because of later collection times, and the second stool 
sample would have greater impact on the sensitivity of AFP surveillance. But even in a well-
functioning APF surveillance system, the second stool sample detected cases that otherwise 
would have been missed, and added sensitivity to detection.
In addition to decreasing the number of stool specimens collected, other options exist for 
potentially reducing the burden of collecting and testing on the surveillance system and the 
laboratory. Returning to the AFP case definition used in India prior to 2005, or maintaining 
environmental sampling at current capacity rather than expanding sites, could achieve this 
goal. However, these scenarios will necessarily decrease sensitivity, to some extent. In 
principle, efforts could be reduced in the laboratory by changing from cell culture-based 
detection of poliovirus to newer molecular methods. Despite advances in these methods, cell 
culture in RD cells remains more sensitive than real-time PCR methods for detection of 
poliovirus from stool specimens [18]. While these methods require less personnel time, the 
cost of reagents is significantly higher if they are to be applied routinely. To date, the GPEI 
has not been willing to trade reduced sensitivity for a faster, but more expensive, laboratory 
result.
In certain circumstances, ending collection and testing of the second stool specimen might 
be appropriate. After examination of data from the Americas, it was suggested that in 
endemic countries with high laboratory proficiency, collection of the second stool sample 
may not be necessary [4, 19, 20]. As a result, a recommendation to collect only one stool 
sample was made by the Pan American Health Organization after certification of polio 
eradication in the Americas. For India, consideration could be given to ending the collection 
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and testing of the second stool specimen in the post-eradication era (following national 
certification 3 years after the last case is reported), if the AFP surveillance system continues 
to be strong. At the present time, however, when identification of every case is critical and 
maximum sensitivity is required to mitigate the risk of failure to detect poliovirus 
importations, our findings support continuing the collection of two stool specimens for AFP 
surveillance in India.
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Fig. 1. 
Sensitivity definitions and calculations (Gary et al. [11]). * Also known as person sensitivity.
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Fig. 2. 
Acute flaccid paralysis (AFP) cases reported, confirmed polio cases reported, and stool 
specimens processed, India, 2000–2010. Confirmed polio cases include wild poliovirus 
(WPV) type 1, WPV type 3, and vaccine-derived poliovirus. ■, AFP cases; ■, laboratory 
samples processed; —, confirmed polio cases.
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Fig. 3. 
Mean time interval from onset of paralysis and arrival of second specimen in laboratories, by 
components, India, 2000–2010. ■, Time from paralysis to collection of first stool sample 
(S1); ■, time from S1 collection to collection of second stool sample (S2); ■, time from S2 
collection to sending S2 to the laboratory; □, time from sending S2 to arrival at the 
laboratory.
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Table 1.
Indicators of stool specimen adequacy, timeliness, condition, and collection for acute flaccid paralysis (AFP) 
cases reported, India, 2000–2010*
N %
Stool adequacy†
 Both stools adequate 248829 85·5
 Either inadequate 5706 1·8
 Both inadequate 36515 12·6
Time of stool specimen collection from onset of paralysis
 Both stools ⩽4 days 250651 86·1
 Only stool 1 ⩽4 days 4766 1·6
 Both stools >14 days 35679 12·3
Stool condition‡
 Both stools good 288892 99·3
 Either poor 1249 0·4
 Both poor 932 0·3
Interval from collection of specimen 1 to collection of specimen 2
 24–48 h 266149 91·3
 >48 h 25202 8·7
*AFP cases with missing data excluded from analysis; for all categories, <5% of all AFP cases in the database.
†Stool adequacy is defined as two stool specimens collected from each AFP case within 14 days of paralysis onset and at least 24 h apart; each 
specimen must be of adequate volume (8–10 g), and arrive at a WHO-accredited laboratory in good condition.
‡A stool specimen in good condition is defined as a specimen that arrives in the laboratory with neither desiccation nor leakage, with adequate 
documentation and evidence that the cold chain was maintained.
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Table 4.
Percentage of polio-confirmed acute flaccid paralysis cases identified only by the second stool specimen, 
India, 2000–2010
Total polio
cases
identified
Cases identified
only by second
stool (%)
P
value*
Overall 5184 382 (7·4)
Stool condition
 Both good 5122 379 (7·4) 0·5421
 Both poor 30 3 (10·0)
Stool adequacy
 Both adequate 4747 328 (6·9) <0·0001
 Both inadequate 350 45 (12·9)
Interval from paralysis onset to collection of first stoolspecimen (days)
 <8 3628 222 (6·1) <0·0001
 8–14 1237 118 (9·5)
 15–21 163 20 (12·4)
 22–60 156 22 (13·9)
Patient age, months
 0–11 1586 104 (6·6) 0·0004
 12–23 2105 141 (6·7)
 24–35 847 72 (8·5)
 36–59 475 43 (9·1)
 60–180 171 22 (12·9)
Time period category
 2000–2004 2406 175 (7·3) 0·7527
 2005–2009 2734 203 (7·4)
 2010 44 4 (9·1)
*P value represents trend test for proportions across ordinal categories.
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